CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 61, Issue 3, Pages 965-978
Publisher
Wiley
Online
2014-11-01
DOI
10.1002/hep.27593
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
- (2013) Q. Huang et al. CANCER RESEARCH
- Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes
- (2013) Anuradha Budhu et al. GASTROENTEROLOGY
- Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification
- (2013) Diren Beyoğlu et al. HEPATOLOGY
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
- (2012) Han Chong Toh et al. CANCER
- How cancer metabolism is tuned for proliferation and vulnerable to disruption
- (2012) Almut Schulze et al. NATURE
- Medical therapies for hepatocellular carcinoma: a critical view of the evidence
- (2012) Augusto Villanueva et al. Nature Reviews Gastroenterology & Hepatology
- C/EBP and C/EBP oncoproteins regulate nfkb1 and displace histone deacetylases from NF- B p50 homodimers to induce NF- B target genes
- (2011) I. Paz-Priel et al. BLOOD
- Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
- (2011) J.-W. Park et al. CLINICAL CANCER RESEARCH
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
- (2011) Gerritje J.W. van der Windt et al. IMMUNITY
- Re-patterning of Skeletal Muscle Energy Metabolism by Fat Storage-inducing Transmembrane Protein 2
- (2011) Diego A. Miranda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- C/EBPα Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation
- (2010) Guo–Dong Lu et al. GASTROENTEROLOGY
- Suppression of Long Chain Acyl-CoA Synthetase 3 Decreases Hepaticde NovoFatty Acid Synthesis through Decreased Transcriptional Activity
- (2009) So Young Bu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition
- (2009) Lei O. Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
- (2009) Annika Dufour et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- In prostate cancer C/EBPα promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT
- (2009) Hong Yin et al. PROSTATE
- Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells
- (2008) Peggy Kirstetter et al. CANCER CELL
- Epigenetic Modification of CCAAT/Enhancer Binding Protein Expression in Acute Myeloid Leukemia
- (2008) B. Hackanson et al. CANCER RESEARCH
- Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia
- (2008) Thomas Pabst et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With,CEBPAMutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
- (2008) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer
- (2008) Steffen Koschmieder et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- C/EBPα or C/EBPα oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-κB p50 bound to the bcl-2 and FLIP gene promoters
- (2008) I Paz-Priel et al. LEUKEMIA
- Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia
- (2008) Edgar Jost et al. LEUKEMIA RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now